{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T08:43:05Z","timestamp":1794559385880,"version":"4.9.1"},"reference-count":41,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2005,7,1]],"date-time":"2005-07-01T00:00:00Z","timestamp":1120176000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Investigation"],"published-print":{"date-parts":[[2005,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:bold>Background\u2002<\/jats:bold> Persistent <jats:italic>Chlamydia pneumoniae<\/jats:italic> infection within atherosclerotic plaques are possible stimulators of inflammation in atherosclerosis. Why the microbe develops persistency in some individuals is unknown, but experimental studies in cell cultures and animals have demonstrated the levels of gamma interferon (IFN\u03b3) and interleukin 10 (IL\u201010) to be of crucial importance.<\/jats:p><jats:p><jats:bold>Design\u2002<\/jats:bold> We wanted to evaluate whether <jats:italic>Chlamydia<\/jats:italic> seropositivity in patients with coronary heart disease (CHD) (<jats:italic>n<\/jats:italic>\u00a0=\u00a0193) was associated with elevated IFN\u03b3 and IL\u201010. Two methods for detection of <jats:italic>Chlamydia<\/jats:italic> antibodies were included as well as analysis of tumour necrosis factor \u03b1 (TNF\u03b1), soluble vascular cell adhesion molecule 1 (sVCAM\u20101) and soluble E\u2010selectin for the evaluation of vascular inflammation.<\/jats:p><jats:p><jats:bold>Results\u2002<\/jats:bold> We found that patients with IgA antibodies towards <jats:italic>Chlamydia<\/jats:italic> lipopolysaccharide (LPS) had elevated levels of IFN\u03b3 (<jats:italic>P<\/jats:italic>\u00a0=\u00a00\u00b7048), IL\u201010 (<jats:italic>P<\/jats:italic>\u00a0=\u00a00\u00b7029), TNF\u03b1 (<jats:italic>P<\/jats:italic>\u00a0=\u00a00\u00b7009) and sE\u2010selectin (<jats:italic>P<\/jats:italic>\u00a0=\u00a00\u00b7045), while Chlamydia LPS IgG seropositivity predicted elevated levels of IL\u201010 (<jats:italic>P<\/jats:italic>\u00a0=\u00a00\u00b7013). Patients with IgA antibodies towards <jats:italic>C. pneumoniae<\/jats:italic> major outer membrane protein (MOMP) without simultaneous LPS IgA seropositivity had lower levels of IFN\u03b3 and sVCAM\u20101 when compared to patients with <jats:italic>Chlamydia<\/jats:italic> LPS IgA alone (<jats:italic>P<\/jats:italic>\u00a0=\u00a00\u00b7005 for IFN\u03b3, <jats:italic>P<\/jats:italic>\u00a0=\u00a00\u00b7016 for VCAM\u20101) and patients with combined <jats:italic>Chlamydia<\/jats:italic> MOMP and LPS IgA seropositivity (<jats:italic>P<\/jats:italic>\u00a0=\u00a00\u00b7046 and <jats:italic>P<\/jats:italic>\u00a0=\u00a00\u00b7013, respectively).<\/jats:p><jats:p><jats:bold>Conclusions\u2002<\/jats:bold> In summary, we demonstrated an association between <jats:italic>Chlamydia<\/jats:italic> LPS IgA seropositivity and elevated levels of IFN\u03b3, IL\u201010, TNF\u03b1, sVCAM\u20101 and sE\u2010selectin in CHD patients that might indicate persistent <jats:italic>Chlamydia<\/jats:italic> infection and a proinflammatory state. On the other hand, <jats:italic>C. pneumoniae<\/jats:italic> MOMP antibodies were not associated with elevated inflammatory markers and might merely be indicative of past infection, possibly with successful microbe clearance.<\/jats:p>","DOI":"10.1111\/j.1365-2362.2005.01511.x","type":"journal-article","created":{"date-parts":[[2005,7,1]],"date-time":"2005-07-01T17:48:41Z","timestamp":1120240121000},"page":"431-437","source":"Crossref","is-referenced-by-count":9,"title":["Chlamydia LPS and MOMP seropositivity are associated with different cytokine profiles in patients with coronary heart disease"],"prefix":"10.1111","volume":"35","author":[{"given":"A.","family":"Schumacher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Seljeflot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. B.","family":"Lerker\u00f8d","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Sommervoll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. E.","family":"Otterstad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Arnesen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2005,7]]},"reference":[{"key":"e_1_2_6_2_2","first-page":"66","article-title":"Chlamydia pneumoniae, strain TWAR and atherosclerosis","volume":"14","author":"Grayston JT","year":"1993","journal-title":"Eur Heart J"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1086\/315614"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.64.5.1614-1620.1996"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-8703(99)70287-5"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1086\/514241"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1006\/mpat.1996.0056"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1165\/ajrcmb.19.5.3072"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1006\/mpat.1996.0071"},{"key":"e_1_2_6_10_2","doi-asserted-by":"crossref","first-page":"4834","DOI":"10.4049\/jimmunol.162.8.4834","article-title":"Signal transduction pathways activated in endothelial cells following infection with Chlamydia pneumoniae","volume":"162","author":"Kr\u00fcll M","year":"1999","journal-title":"J Immunol"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(88)90741-6"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(99)00507-0"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/26.4.730"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.39.5.1859-1864.2001"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1128\/MMBR.58.4.686-699.1994"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-8703(99)70283-8"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.62.6.2270-2276.1994"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1699-0463.1995.tb01436.x"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.69.5.3082-3091.2001"},{"key":"e_1_2_6_20_2","doi-asserted-by":"crossref","first-page":"575","DOI":"10.4049\/jimmunol.138.2.575","article-title":"Protective monoclonal antibodies recognize epitopes located on the major outer membrane protein of Chlamydia trachomatis","volume":"138","author":"Zhang YX","year":"1987","journal-title":"J Immunol"},{"key":"e_1_2_6_21_2","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1128\/iai.63.5.1870-1875.1995","article-title":"Potentiation of interferon\u2010mediated inhibition of Chlamydia infection by interleukin 1 in human macrophage cultures","volume":"63","author":"Carlin JM","year":"1995","journal-title":"Infect Immun"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.164.10.5522"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.69.12.7880-7888.2001"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1002\/jemt.1093"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1469-0691.2002.00439.x"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9150(02)00043-6"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.164.9.4812"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.162.5.2829"},{"key":"e_1_2_6_29_2","doi-asserted-by":"crossref","first-page":"4338","DOI":"10.4049\/jimmunol.156.11.4338","article-title":"Genetically determined differences in IL\u201010 and IFN\u2010\u03b3 responses correlate with clearance of Chlamydia trachomatis mouse pneumonitis infection","volume":"156","author":"Yang X","year":"1996","journal-title":"J Immunol"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.hjr.0000107024.38316.6a"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2003.09.001"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.68.10.6038-6040.2000"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1086\/315856"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.68.12.7156-7158.2000"},{"key":"e_1_2_6_35_2","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1128\/IAI.67.5.2682-2686.1999","article-title":"Gamma interferon and interleukin 10 gene expression in synovial tissues from patients with early stages of Chlamydia\u2010associated arthritis and undifferentiated oligoarthritis and from healthy volunteers","volume":"67","author":"Kotake S","year":"1999","journal-title":"Infect Immun"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.2003.02048.x"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.eurheartj.a015403"},{"key":"e_1_2_6_38_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.57.10.3250-3253.1989"},{"key":"e_1_2_6_39_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.166.3.2018"},{"key":"e_1_2_6_40_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.105.10.1158"},{"key":"e_1_2_6_41_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/155.4.749"},{"key":"e_1_2_6_42_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-3083.1998.00332.x"}],"container-title":["European Journal of Clinical Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2362.2005.01511.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2362.2005.01511.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T16:15:23Z","timestamp":1697213723000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2362.2005.01511.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,7]]},"references-count":41,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2005,7]]}},"alternative-id":["10.1111\/j.1365-2362.2005.01511.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2362.2005.01511.x","archive":["Portico"],"relation":{},"ISSN":["0014-2972","1365-2362"],"issn-type":[{"value":"0014-2972","type":"print"},{"value":"1365-2362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,7]]}}}